Ray Lieh Yoon Low

Title: Ray Lieh Yoon Low: Innovator in Bispecific Antibodies

Introduction

Ray Lieh Yoon Low is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work has the potential to impact therapeutic applications in various medical fields.

Latest Patents

Ray Lieh Yoon Low holds a patent for "Bispecific antibodies with cleavable C-terminal charge-paired tags." This invention is directed to a CH3-containing molecule that comprises a first polypeptide with a CH3 domain and a negatively charged domain, as well as a second polypeptide with a CH3 domain and a positively charged domain. The patent outlines methods for conjugating synthetic molecules to a multi-specific antigen binding molecule, showcasing his expertise in molecular design.

Career Highlights

Ray is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Some of Ray's coworkers include John K Kawooya and Alex W Jacobitz. Their collaboration fosters a creative environment that encourages innovation and the development of groundbreaking technologies.

Conclusion

Ray Lieh Yoon Low is a distinguished inventor whose work in bispecific antibodies exemplifies the intersection of science and innovation. His contributions to biotechnology continue to pave the way for advancements in medical therapies.